Prostate cancer: San Carlo di Nancy Hospital honored as a center specializing in the treatment of the disease
San Carlo di Nancy Hospital in Rome is among the multidisciplinary centers awarded with the Blue Stamp (2022-2023), important recognition of Onda Foundation, National Observatory on Women’s Health and Gender, awarded to hospitals that adopt an interdisciplinary approach in diagnostic and therapeutic pathways dedicated to people with prostate cancer. This is the first edition of this national call for proposals, and the first award among those promoted by the Onda Foundation whose subject is human health.
New diagnoses of prostate cancer
Italy new diagnoses of prostate cancer are about 36.000 each year out of a total of about 564.000 men with prostate cancer, accounting for 19 percent of cancer cases in the male population.
“The Bollino Azzurro is further recognition of the approach we have chosen to take in – comments the prof. Pierluigi Bove, head of the Urology Operating Unit at St. Charles of Nancy Hospital -, namely, a multidisciplinary approach, with individualized diagnostic and treatment pathways and through synergistic collaboration between different specialists. At our center we also use the most innovative technologies, such as the da Vinci robotic system and the Echolaser, which allow us to intervene in a minimally invasive and conservative manner in the removal of the neoplasm, while respecting the healthy parts that are preserved, being able to offer the patient a recovery of function in most cases.”.
The use of these cutting-edge technologies
The use of these cutting-edge technologies and minimally invasive treatments allow additional advantages for the patient, such as shorter operating room times and faster postoperative recovery with less pain; in addition, minimally invasive allows for a reduced risk of complications and infections compared to traditional open surgery.
Urologist, radiation oncologist, medical oncologist, pathologist, radiologist, nuclear medicine physician, psychologist, together with the health management, accompany the patient in a comprehensive pathway, which includes prevention, diagnosis and treatment of the pathology. Together they also contribute to the achievement of the same goals, viz improve accessibility to the services provided, enhance the level of therapeutic and diagnostic offerings, improve the quality of life of people with prostate cancer, and promote informed among the male population about centers that can implement better patient care.
The awarding of Blue Stamps
The awarding of Blue Stamps has been based on an evaluation, aimed at measuring the quality and multidisciplinarity of services. Parameters that have earned the San Carlo di Nancy Hospital Blue Stamps include: the average number of new cases of prostate cancer treated by the facility, which must be greater than 100; offering a multidisciplinary approach to the management of the disease; the core team consisting of urologist, medical oncologist, and radiation oncologist, to which must be added anatomo-pathologist and imaging specialist. Finally, participation in sessions and continuing education programs on the subject of prostate cancer was also a key feature in gaining recognition.
The initiative is sponsored by AIRO (Italian Association of Radiotherapy and Clinical Oncology), CIPOMO (Italian College of Primary Hospital Medical Oncologists), AIOM (Italian Association of Medical Oncology) Foundation, ROPI (Patients Oncology Network Italy) and SIUrO (Italian Society of Uro-Oncology).